Bottom line
How much do XLV and PRHSX overlap?
80% of their top holdings overlap by weight. 17 securities appear in both funds' top 25, making up 74.5% of XLV's assets and 58.0% of PRHSX's. They are largely the same portfolio — owning both adds little diversification.
PRHSX holds far more positions (279 vs 65), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings XLV and PRHSX have in common
| Holding | % of XLV | % of PRHSX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 16.51% | 14.28% | 14.28% |
| Johnson & Johnson | 10.64% | 6.63% | 6.63% |
| AbbVie Inc | 7.74% | 5.10% | 5.10% |
| UnitedHealth Group Inc | 6.57% | 5.99% | 5.99% |
| Merck & Co Inc | 5.52% | 4.01% | 4.01% |
| Amgen Inc | 3.40% | 1.82% | 1.82% |
| Thermo Fisher Scientific Inc | 3.24% | 2.52% | 2.52% |
| Abbott Laboratories | 2.75% | 1.89% | 1.89% |
| Gilead Sciences Inc | 2.73% | 2.82% | 2.73% |
| Intuitive Surgical Inc | 2.45% | 1.87% | 1.87% |
| CVS Health Corp | 2.30% | 0.94% | 0.94% |
| Vertex Pharmaceuticals Inc | 2.19% | 2.28% | 2.19% |
| Danaher Corp | 2.09% | 1.43% | 1.43% |
| Bristol-Myers Squibb Co | 2.05% | 2.11% | 2.05% |
| Stryker Corp | 1.89% | 1.78% | 1.78% |
| Elevance Health Inc | 1.46% | 1.53% | 1.46% |
| Cardinal Health Inc | 0.97% | 1.03% | 0.97% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in XLV
- Pfizer Inc — 2.39%
- Medtronic PLC — 1.75%
- McKesson Corp — 1.58%
- Cigna Group/The — 1.27%
- Boston Scientific Corp — 1.10%
- Regeneron Pharmaceuticals Inc — 1.08%
- HCA Healthcare Inc — 1.05%
- Cencora Inc — 0.96%
Only in PRHSX
- Natera Inc — 1.44%
- Guardant Health Inc — 1.23%
- Royalty Pharma Plc- Cl A — 0.97%
- Tenet Healthcare Corp — 0.94%
- Kymera Therapeutics Inc — 0.89%
- Protagonist Therapeutics Inc — 0.85%
- Moderna Therapeutics Inc — 0.83%
- Brightspring Health Services — 0.82%
Asset mix
| Asset type | XLV | PRHSX |
|---|---|---|
| Stocks | 99.7% | 96.4% |
| Preferred stock | — | 3.0% |
| Cash & short-term funds | 0.3% | 0.7% |
| Bonds | — | 0.2% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Country mix
| Country | XLV | PRHSX |
|---|---|---|
| US | 97.9% | 92.6% |
| IE | 2.1% | 0.8% |
| GB | — | 1.7% |
| NL | — | 1.0% |
| BM | — | 0.7% |
| DK | — | 0.7% |
| CA | — | 0.6% |
| CH | — | 0.5% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do XLV and PRHSX overlap?
What stocks do XLV and PRHSX have in common?
Should I own both XLV and PRHSX?
Which holds more stocks, XLV or PRHSX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.